Esophageal Cancer: Tumor-Node-Metastasis Staging

Sonia L. Betancourt-Cuellar; Marcelo F.K. Benveniste; Diana P. Palacio; Wayne L. Hofstetter

doi:10.1016/j.rcl.2020.11.008

Esophageal Cancer: Tumor-Node-Metastasis Staging

Sonia L. Betancourt-Cuellar, Marcelo F.K. Benveniste, Diana P. Palacio, Wayne L. Hofstetter

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Esophageal cancer is an uncommon malignancy that ranks sixth in terms of mortality worldwide. Squamous cell carcinoma is the predominant histologic subtype worldwide whereas adenocarcinoma represents the majority of cases in North America, Australia, and Europe. Esophageal cancer is staged using the American Joint Committee on Cancer and the International Union for Cancer Control TNM system and has separate classifications for the clinical, pathologic, and postneoadjuvant pathologic stage groups. The determination of clinical TNM is based on complementary imaging modalities, including esophagogastroduodenoscopy/endoscopic ultrasound; endoscopic ultrasound–fine-needle aspiration; computed tomography of the chest, abdomen, and pelvis; and fluorodeoxyglucose PET/computed tomography.

Original language	English (US)
Pages (from-to)	219-229
Number of pages	11
Journal	Radiologic Clinics of North America
Volume	59
Issue number	2
DOIs	https://doi.org/10.1016/j.rcl.2020.11.008
State	Published - Mar 2021

Keywords

Computed tomography
Endoscopic ultrasound
Esophageal cancer
FDG positron emission tomography/computed tomography
TNM staging system

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rcl.2020.11.008

Cite this

@article{c861c357f8b34ae29be2e5cdaf910bc4,

title = "Esophageal Cancer: Tumor-Node-Metastasis Staging",

abstract = "Esophageal cancer is an uncommon malignancy that ranks sixth in terms of mortality worldwide. Squamous cell carcinoma is the predominant histologic subtype worldwide whereas adenocarcinoma represents the majority of cases in North America, Australia, and Europe. Esophageal cancer is staged using the American Joint Committee on Cancer and the International Union for Cancer Control TNM system and has separate classifications for the clinical, pathologic, and postneoadjuvant pathologic stage groups. The determination of clinical TNM is based on complementary imaging modalities, including esophagogastroduodenoscopy/endoscopic ultrasound; endoscopic ultrasound–fine-needle aspiration; computed tomography of the chest, abdomen, and pelvis; and fluorodeoxyglucose PET/computed tomography.",

keywords = "Computed tomography, Endoscopic ultrasound, Esophageal cancer, FDG positron emission tomography/computed tomography, TNM staging system",

author = "Betancourt-Cuellar, {Sonia L.} and Benveniste, {Marcelo F.K.} and Palacio, {Diana P.} and Hofstetter, {Wayne L.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = mar,

doi = "10.1016/j.rcl.2020.11.008",

language = "English (US)",

volume = "59",

pages = "219--229",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Esophageal Cancer

T2 - Tumor-Node-Metastasis Staging

AU - Betancourt-Cuellar, Sonia L.

AU - Benveniste, Marcelo F.K.

AU - Palacio, Diana P.

AU - Hofstetter, Wayne L.

PY - 2021/3

Y1 - 2021/3

N2 - Esophageal cancer is an uncommon malignancy that ranks sixth in terms of mortality worldwide. Squamous cell carcinoma is the predominant histologic subtype worldwide whereas adenocarcinoma represents the majority of cases in North America, Australia, and Europe. Esophageal cancer is staged using the American Joint Committee on Cancer and the International Union for Cancer Control TNM system and has separate classifications for the clinical, pathologic, and postneoadjuvant pathologic stage groups. The determination of clinical TNM is based on complementary imaging modalities, including esophagogastroduodenoscopy/endoscopic ultrasound; endoscopic ultrasound–fine-needle aspiration; computed tomography of the chest, abdomen, and pelvis; and fluorodeoxyglucose PET/computed tomography.

AB - Esophageal cancer is an uncommon malignancy that ranks sixth in terms of mortality worldwide. Squamous cell carcinoma is the predominant histologic subtype worldwide whereas adenocarcinoma represents the majority of cases in North America, Australia, and Europe. Esophageal cancer is staged using the American Joint Committee on Cancer and the International Union for Cancer Control TNM system and has separate classifications for the clinical, pathologic, and postneoadjuvant pathologic stage groups. The determination of clinical TNM is based on complementary imaging modalities, including esophagogastroduodenoscopy/endoscopic ultrasound; endoscopic ultrasound–fine-needle aspiration; computed tomography of the chest, abdomen, and pelvis; and fluorodeoxyglucose PET/computed tomography.

KW - Computed tomography

KW - Endoscopic ultrasound

KW - Esophageal cancer

KW - FDG positron emission tomography/computed tomography

KW - TNM staging system

UR - http://www.scopus.com/inward/record.url?scp=85100404443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100404443&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2020.11.008

DO - 10.1016/j.rcl.2020.11.008

M3 - Review article

C2 - 33551083

AN - SCOPUS:85100404443

SN - 0033-8389

VL - 59

SP - 219

EP - 229

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

IS - 2

ER -

Esophageal Cancer: Tumor-Node-Metastasis Staging

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this